· Molecular mechanisms and targets in complement-related diseases

· Novel inhibitors & pipeline compounds

· Informative complement biomarkers in therapeutic development

· Hematological disorders

· Organ & cell transplantation, I/R injury and chronic rejection

· Kidney diseases

· Neurological & ocular diseases

· Acute and chronic inflammatory disorders

· Infectious diseases & sepsis

· Cancer

· Novel and unexpected indications